Labaran Masana'antu

  • 2021 FDA Sabbin Magunguna 1Q-3Q

    Kirkiro yana haifar da ci gaba. Idan ya zo ga ƙira a cikin haɓaka sabbin magunguna da samfuran ilimin halittu masu warkarwa, Cibiyar Nazarin Magunguna da Bincike ta FDA (CDER) tana tallafawa masana'antar magunguna a kowane mataki na aiwatarwa. Tare da fahimtar ta ...
    Kara karantawa
  • Recent developments of Sugammadex Sodium in the wake period of anesthesia

    Abubuwan da ke faruwa na kwanan nan na Sugammadex Sodium a lokacin farkawa

    Sugammadex Sodium sabon ɗan adawa ne na zaɓaɓɓen murɗaɗɗen murɗaɗɗen tsoka (myorelaxants), wanda aka fara ba da rahotonsa a cikin mutane a 2005 kuma tun daga lokacin aka fara amfani da shi a asibiti a Turai, Amurka da Japan. Idan aka kwatanta da magungunan antiholinesterase na gargajiya ...
    Kara karantawa
  • Which tumors are thalidomide effective in treating!

    Waɗanne ciwace -ciwacen ne thalidomide masu tasiri a cikin jiyya!

    Thalidomide yana da tasiri wajen magance waɗannan ciwace -ciwacen! 1. A cikin abin da m tumor za a iya amfani da thalidomide. 1.1. ciwon huhu. 1.2. Ciwon daji na prostate. 1.3. nodal rectal cancer. 1.4. ciwon hanta hepatocellular. 1.5. Ciwon daji na ciki. ...
    Kara karantawa
  • Apixaban and Rivaroxaban

    Apixaban da Rivaroxaban foda

    A cikin 'yan shekarun nan, tallace -tallace na apixaban ya haɓaka cikin sauri, kuma kasuwar duniya ta riga ta wuce rivaroxaban. Saboda Eliquis (apixaban) yana da fa'ida akan warfarin wajen hana bugun jini da zubar jini, kuma Xarelto (Rivaroxaban) kawai ya nuna rashin kaskanci. Bugu da kari, Apixaban baya ...
    Kara karantawa
  • Abubuwa masu guba

    A ranar 29 ga Yuni, Intercept Pharmaceuticals ta ba da sanarwar cewa ta karɓi cikakken sabon aikace-aikacen magunguna daga FDA ta Amurka game da FXR agonist obeticholic acid (OCA) don fibrosis da wasiƙar Amsar steatohepatitis (NASH) (CRL) ta haifar. FDA ta bayyana a cikin CRL cewa dangane da bayanan ...
    Kara karantawa
  • Remdesivir

    A ranar 22 ga Oktoba, lokacin Gabas, FDA ta Amurka a hukumance ta amince da Veklury (remdesivir) na Gileyad don amfani a cikin tsofaffi masu shekaru 12 da haihuwa kuma suna auna aƙalla kilogram 40 da ke buƙatar asibiti da magani na COVID-19. A cewar FDA, Veklury a halin yanzu shine kawai FDA ta amince da COVID-19 t ...
    Kara karantawa
  • Sanarwar amincewa da Rosuvastatin Calcium

    Kwanan nan, Nantong Chanyoo ya sake yin wani babban tarihi a cikin tarihi! Tare da ƙoƙarin sama da shekara ɗaya, MFDS ta karɓi KDMF na Chanyoo na farko. A matsayin babbar masana'anta na Rosuvastatin Calcium a China, muna fatan buɗe sabon babin a kasuwar Koriya. Kuma ƙarin samfuran za su b ...
    Kara karantawa
  • Yadda Fette Compacting China ke tallafawa yaƙi da COVID-19

    Cutar COVID-19 ta duniya ta canza mayar da hankali ga rigakafin annoba da sarrafa kamuwa da cuta a duk sassan duniya. Hukumar ta WHO ba ta yin wani kokari don kiran dukkan kasashe don karfafa hadin kai da hadin gwiwa don yakar barkewar cutar. An nemi duniyar kimiyya ...
    Kara karantawa
  • CPhI & P-MEC China 2019 sun yi bikin kuma sun sami babban nasara ga masana'antar harhada magunguna ta Changzhou!

    R&D MANAGEMENT Cikakken dandamalin R&D Gina Cibiyar Nazarin Magungunan Magunguna, mallakar tashar wayar tafi da gidanka ta digiri na biyu, haɗa albarkatu gabaɗaya, hanzarta ci gaban ...
    Kara karantawa